Carregant...
Warfarin Dosing in Patients With Impaired Kidney Function
BACKGROUND: Warfarin, a drug primarily metabolized by the cytochrome P450 system, is initiated at similar doses and managed similarly in patients with kidney impairment as in the general medical population. Unfortunately, few data exist to guide dose adjustment in patients with reduced kidney functi...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2963672/ https://ncbi.nlm.nih.gov/pubmed/20709439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2010.05.023 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|